Latest Breaking News On - Patients hospitalized - Page 1 : vimarsana.com

New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease

WILMINGTON, Del. (BUSINESS WIRE) May 19, 2024

United kingdomUnited statesLymphopoietin isoformsDave singhBrendan mcevoyJillian gonzalesSharon barrGlobal initiative on obstructive lung diseaseCenters for diseaseInternational conferenceAmerican thoracic societyNational heartAmerican lung associationUniversity of manchesterBlood instituteGlobal initiative for chronic obstructive lung disease

Despite its nothingburger reputation, COVID-19 remains deadlier than the flu

Despite its nothingburger reputation, COVID-19 remains deadlier than the flu
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesRyan xieZiyad al alyPeter chin hongLos angeles timesCenters for diseaseTribune content agencyLouis health care systemClinical epidemiology centerVeterans affairsJournal of the american medical associationAmerican medicalDisease controlPatients hospitalized

Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024

Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

Patients hospitalized

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

New data for TEZSPIRE and BREZTRI demonstrate AstraZeneca’s innovation and commitment to transform care in COPD .

San diegoUnited statesEast sussexUnited kingdomSharon barrLymphopoietin isoformsAmerican lung associationInternational conferenceGlobal initiative on obstructive lung diseaseKyowa kirin co ltdAmerican thoracic society international conferenceGlobal asthma networkBiowa incAmerican partnership for eosinophilic disordersNational heartBlood institute

60 Degrees Pharmaceuticals (SXTP) Announces IRB Approval of Phase IIA Study of Tafenoquine for Babesiosis

60 Degrees Pharmaceuticals (SXTP) Announces IRB Approval of Phase IIA Study of Tafenoquine for Babesiosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDegrees pharmaceuticals incDrug administrationInvestigational review boardBabesiosis studythe phasePlacebo controlled studyOral tafenoquinePatients hospitalized